Tímea Teszák
YOU?
Author Swipe
View article: Donor-Derived Cell-Free DNA Versus Left Ventricular Longitudinal Strain and Strain-Derived Myocardial Work Indices for Identification of Heart Transplant Injury
Donor-Derived Cell-Free DNA Versus Left Ventricular Longitudinal Strain and Strain-Derived Myocardial Work Indices for Identification of Heart Transplant Injury Open
Background/Objectives: Donor-derived cell-free DNA (dd-cfDNA) is a marker of graft injury that increases in acute rejection and has excellent negative predictive value. Left ventricular global longitudinal strain (LVGLS) and strain-derived…
View article: Noninvazív rejekció utánkövetése szolid szervek átültetését követően: a donoreredetű sejtmentes DNS vizsgálata
Noninvazív rejekció utánkövetése szolid szervek átültetését követően: a donoreredetű sejtmentes DNS vizsgálata Open
A szolidszerv-transzplantátum kilökődése a modern immunszuppresszív kezelés mellett is a graftdiszfunkció, a hospitalizáció és a halálozás egyik fő etiológiai tényezője. A rejekció diagnosztikájában ’gold standard’ invazív biopszia azonban…
View article: Trajectory of Diastolic Function after Heart Transplantation as Assessed by Left Atrial Deformation Analysis
Trajectory of Diastolic Function after Heart Transplantation as Assessed by Left Atrial Deformation Analysis Open
Diastolic dysfunction (DD) is a prevalent and clinically significant complication after heart transplantation (HTX). We aimed to characterize the diastolic function of HTX recipients with both short-term and long-term follow-ups by applyin…
View article: Preoperative examination of inflammatory biomarkers in relation to the prognosis of postoperative complications after heart transplantation
Preoperative examination of inflammatory biomarkers in relation to the prognosis of postoperative complications after heart transplantation Open
Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Semmelweis University Heart transplantation (HTX) is the definitive therapy for end-stage heart failure. Although complications have drastically …
View article: Seroconversion after SARS‐CoV‐2 vaccination is protective against severe COVID‐19 disease in heart transplant recipients
Seroconversion after SARS‐CoV‐2 vaccination is protective against severe COVID‐19 disease in heart transplant recipients Open
Background Heart transplant (HTX) recipients are prone to develop complications after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Vaccination is often ineffective due to weaker immunogenicity. In this high‐volum…
View article: Non-invasive rejection surveillance in stable heart transplantation using local laboratory-run donor-derived cell-free DNA assay: two-centre European feasibility study
Non-invasive rejection surveillance in stable heart transplantation using local laboratory-run donor-derived cell-free DNA assay: two-centre European feasibility study Open
Background Monitoring adverse events is crucial after heart transplantation (HTx). Allograft rejection is a major etiological factor of graft dysfunction, hospitalisation, and death posttransplant. Endomyocardial biopsy (EMB) is the standa…
View article: Local laboratory‐run donor‐derived cell‐free DNA assay for rejection surveillance in heart transplantation—first six months of clinical experience
Local laboratory‐run donor‐derived cell‐free DNA assay for rejection surveillance in heart transplantation—first six months of clinical experience Open
Our data show the feasibility to analyze dd-cfDNA at the local level and successful implementation of this non-invasive surveillance method into clinical practice, thus considerably reducing the frequency of invasive surveillance EMBs.
View article: European multicenter study on the real-world use and clinical impact of extracorporeal photopheresis after heart transplantation
European multicenter study on the real-world use and clinical impact of extracorporeal photopheresis after heart transplantation Open
This study, the largest European ECP study in heart transplantation, demonstrates that ECP can effectively be used to treat different rejection types and to prevent rejection in the modern era of immunosuppression. Patients with rejections…
View article: Szívtranszplantációt követő kilökődés noninvazív diagnosztikája : A donoreredetű sejtmentes DNS mérésének lehetősége a gondozás során
Szívtranszplantációt követő kilökődés noninvazív diagnosztikája : A donoreredetű sejtmentes DNS mérésének lehetősége a gondozás során Open
Bevezetés: A szívtranszplantátum kilökődése a modern immunszuppresszív gyógyszeres kezelés mellett is a graftdiszfunkció, hospitalizáció és halálozás egyik fő etiológiai tényezője. A rejekció diagnosztikájában használatos, reguláris survei…
View article: Pseudoaneurysm of the ascending aorta: case report of a donor-derived Pseudomonas infection in a heart transplant recipient
Pseudoaneurysm of the ascending aorta: case report of a donor-derived Pseudomonas infection in a heart transplant recipient Open
Background Mycotic aortic pseudoaneurysm is a rare complication after heart transplantation (HTX) with remarkable mortality. Intrathoracic infection is a well-documented predisposing factor for this disease. Staphylococcus aureus , Pseudom…
View article: Jobbszívfél-elégtelenség évekkel a szívtranszplantációt követően : Egy ritka etiológiai tényező esete
Jobbszívfél-elégtelenség évekkel a szívtranszplantációt követően : Egy ritka etiológiai tényező esete Open
View article: Temporal changes of left atrial function after orthotopic heart transplantation using cardiac magnetic resonance imaging in a single-center prospective study
Temporal changes of left atrial function after orthotopic heart transplantation using cardiac magnetic resonance imaging in a single-center prospective study Open
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): ÚNKP-19-3-I New National Excellence Program of the Ministry for Innovation and Technology; National Research, Development and…